Found vs Telos Rx: Biology-First Plans vs Compounded GLP-1 Pricing
Found vs Telos Rx compares a biology-first weight-loss program with an insurer-friendly model (Found) against a clinician-reviewed, medication-focused service that lists compounded semaglutide from $99 and tirzepatide from $139 (Telos Rx). Early verdict: choose Found if you want a personalized, medically supervised plan that accepts many insurance plans; choose Telos Rx if you are focused on compounded semaglutide or tirzepatide pricing and immediate medication options pending clinician approval.
Explore Found plans starting at $39
How the approaches differ: biology-first versus medication-first
Found frames itself as a “biology-first” program that builds a personalized medically supervised weight-loss plan around hormones, blood sugar regulation, sleep, and behavior. Telos Rx presents a medication-centric offering: compounded semaglutide and tirzepatide prescribed online after review by a US-licensed provider, emphasizing GLP-1 and GLP-1 + GIP options. Both note that compounded medications are not FDA-approved; Found explicitly calls out compounded semaglutide and tirzepatide and includes regulatory language that they are not FDA-approved and not available in all states. Telos Rx also states compounded medications are not FDA-approved and that treatment is available only when a licensed clinician determines it is medically appropriate.
Clinical review and eligibility
Both platforms require clinician review. Found says Rx is subject to provider review and clinical eligibility; Telos Rx similarly requires approval by a US-licensed provider and notes pay $0 if not approved in some captured messaging. Telos Rx emphasizes that a licensed provider decides whether semaglutide or tirzepatide is right for the patient, while Found emphasizes a broader medical evaluation that informs a personalized plan.
See Telos Rx medication pricing from $99
Pricing and insurance: starting costs and coverage differences
Found lists “get started for as low as $39” and states most insurance is now accepted, with Found handling insurance paperwork and noting specific programs like a Medicare GLP-1 Bridge Program in captured landing-page evidence. Found also provides multiple starting figures across plan types in the captured evidence. Telos Rx lists semaglutide as low as $99 per month and tirzepatide as low as $139 per month, and includes statements like “as low as $99 per month” and “pay $0 if not approved” in captured messaging. Telos Rx warns that pricing, eligibility, pharmacy, state coverage, and renewal terms may change and that your price depends on your plan.
Medications offered and compounded status
Both providers offer GLP-1 class medications and reference compounded semaglutide and tirzepatide. Found lists tirzepatide and semaglutide and notes brand-name options in captured offers while preserving the regulatory note that compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy and not available in all states. Telos Rx specifies semaglutide acts on GLP-1 and tirzepatide acts on GLP-1 plus GIP, and that both are compounded and prescription-only.
| Criterion | Found | Telos Rx |
|---|---|---|
| Starting price | Get started for as low as $39 | Semaglutide as low as $99; tirzepatide as low as $139 |
| Approach | Biology-first personalized medically supervised program | Medication-focused, clinician-reviewed GLP-1 and GIP options |
| Insurance | Most insurance now accepted; Found handles paperwork | Price depends on plan; coverage and terms may change |
| Medications | Semaglutide, tirzepatide, brand-name mentions captured | Compounded semaglutide and tirzepatide prescribed online |
| Compounded status | Compounded GLP-1s not FDA-approved or evaluated for safety or efficacy | Compounded medications not FDA-approved; clinician approval required |
| Cancellation | Affordable monthly plans. Cancel anytime (captured) | Cancel anytime, no penalties (captured) |
Compare Found membership details
What users should verify before enrolling
Both sources advise checking clinician eligibility and state availability. Found highlights insurance coverage, copays, coinsurance, deductibles, and that compounded GLP-1s are not available in all states. Telos Rx warns that pricing, eligibility, pharmacy, state coverage, and renewal terms may change and that treatment is available only when a licensed clinician determines it is medically appropriate. Neither source supplies guaranteed clinical outcomes.
Confirm Telos Rx eligibility and pricing
Final thoughts on Found vs Telos Rx
Found vs Telos Rx contrasts a broader biologic, personalized program with insurer integration (Found) against a medication-centric, clinician-reviewed online service with explicit per-medication pricing (Telos Rx). Both disclose that compounded medications are not FDA-approved and that prescriptions are subject to provider review and clinical eligibility. Found emphasizes insurance handling, flexible monthly starts as low as $39, and a holistic approach. Telos Rx emphasizes semaglutide from $99 and tirzepatide from $139 when approved by a clinician.
Choose Found if you want a personalized, medically supervised program that accepts many insurance plans and handles paperwork. Choose Telos Rx if your priority is clinician-reviewed access to compounded semaglutide or tirzepatide with the specific starting prices Telos Rx lists.
Found vs Telos Rx is intended to clarify differences; verify current pricing, insurance acceptance, state availability, and clinician eligibility directly with each provider before enrolling.